VBIV
VBI Vaccines Inc
NASDAQ: VBIV · HEALTHCARE · BIOTECHNOLOGY
$0.07
+0.00% today
Updated 2026-04-29
Market cap
$1.87M
P/E ratio
—
P/S ratio
0.20x
EPS (TTM)
$-3.54
Dividend yield
—
52W range
$0 – $0
Volume
—
VBI Vaccines Inc (VBIV) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-69.0%
Last 4 quarters
Revenue YoY growth
+150.3%
Most recent quarter
EPS YoY growth
+77.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-03-31 | $-0.53 | $-0.73 | -37.7% | $1.21M | +150.3% |
| 2023-12-31 | $-0.22 | $-0.01 | +95.5% | $853000.00 | +191.1% |
| 2023-09-30 | $-0.14 | $-1.01 | -621.4% | $6.62M | +1989.6% |
| 2023-06-30 | $-2.16 | $-5.05 | -133.8% | $720000.00 | +108.1% |
| 2023-03-31 | $-1.25 | $-3.22 | -157.6% | $485000.00 | +284.9% |
| 2022-12-31 | $-0.07 | $-0.08 | -14.3% | $293000.00 | +261.7% |
| 2022-09-30 | $-0.08 | $-0.09 | -12.5% | $317000.00 | +196.3% |
| 2022-06-30 | $-0.07 | $-0.18 | -157.1% | $346000.00 | +143.7% |
| 2022-03-31 | $-0.08 | $-0.08 | +0.0% | $126000.00 | — |
| 2021-12-31 | $-0.07 | $-0.07 | +0.0% | $81000.00 | — |
| 2021-09-30 | $-0.07 | $-0.06 | +14.3% | $107000.00 | — |
| 2021-06-30 | $-0.06 | $-0.07 | -16.7% | $142000.00 | — |
Frequently asked questions
Has VBI Vaccines Inc beaten earnings estimates?
VBI Vaccines Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -69.0% over the last 4 quarters.
What is VBI Vaccines Inc's revenue growth rate?
VBI Vaccines Inc reported year-over-year revenue growth of +150.3% in its most recent quarter, with EPS growing +77.3% year-over-year.